Asked | Open questions | Answered Points Date Pair Term / Answer given Level Status Gloss 4 Feb 22 eng>fra 2'-O-2 methoxyethyl (2-MOE) 2'-O-2 méthoxyéthyle (2-MOE) pro closed no - Dec 14 '23 eng>fra Adeno‑Associated Virus Vector–Mediated Gene Transfer Transfert de gènes à l'aide de vecteurs dérivés du virus adéno-associé pro closed ok 4 Oct 6 '23 eng>fra silhouette view vue de silhouette pro closed no 4 Oct 4 '23 eng>fra backfill cohort cohorte backfill ou cohorte d'inclusion/d'ajout de patients supplémentaires pro closed no 4 Sep 29 '23 eng>fra MMD responders Répondeurs JMM pro closed ok 4 Sep 11 '23 eng>fra weightbearing mise en charge pro closed no 4 Jul 31 '23 eng>fra finite regimen schéma à durée fixe/définie pro closed no - Apr 23 '23 eng>fra Challenge drugs Mettre à l’épreuve (les médicaments qui..) pro closed ok 4 Mar 29 '23 eng>fra pharmacokinetic bridging comparabilité pharmacocinétique pro closed no - Jan 26 '23 eng>fra derived from dérivé de pro closed ok - Jan 23 '23 eng>fra chloride form forme chlorure pro closed no - Jun 7 '20 eng>fra LCM Système de gestion de contenu juridique pro closed ok - May 30 '19 eng>fra AL PE liner revêtement polyéthylène aluminium pro closed ok - May 26 '19 eng>fra the out of specifications (OOS) hors spécifications pro closed ok - Oct 2 '18 eng>fra signature peptide assay test de signature peptidique pro closed ok - Aug 10 '18 eng>fra 30's Count Boîte de 30 comprimés easy closed ok - Nov 10 '17 eng>fra Fluorescence ratio rapport (ratio) de fluorescence pro closed ok - Oct 11 '17 eng>fra repurposing repositionnement / réorientation / reprofilage pro closed ok 4 Jun 2 '17 eng>fra sham-control patients / sham-controlled study / sham procedure patients du groupe témoin / étude contrôlée par placebo / procédure placebo pro closed no - Mar 5 '17 eng>fra rank analysis of covariance model modèle d'analyse de covariance par rang / Analyse de variance de Quade pro closed ok - Mar 2 '17 eng>fra CORE CLAIM revendication de base pro closed ok - Feb 23 '17 eng>fra crossover switching studies études croisées de permutation pro closed ok - Feb 23 '17 eng>fra multi-switching PK/PD assessment évaluation pharmacocinétique/pharmacodynamique à commutations multiples de traitement pro closed ok - Feb 23 '17 eng>fra add-on effect effet additif easy closed ok 4 Feb 22 '17 eng>fra HMWs, % Pourcentage de produits de haut poids moléculaire pro closed no - Feb 12 '17 eng>fra was approximately 1.3‑2.2 fold in plasma. La concentration plasmatique de M1 est environ 1.3 à 2.2 fois plus importante que celle de x. pro just_closed no - Feb 7 '17 eng>fra policy politique pro closed no 4 Feb 6 '17 eng>fra reprint carrier support d'article de journal médical pro closed no - Feb 6 '17 eng>fra ADCC potency puissance de la cytotoxicité à médiation cellulaire dépendante des anticorps (ADCC) pro closed ok 4 Feb 4 '17 eng>fra taxadiene core noyau en taxadiène pro closed no Asked | Open questions | Answered